Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Langman

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Lupus|January 10, 2018
Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controlsI G Poornima, K Shields, L H Kuller, et al.
Implementation Science Communications|March 8, 2022
A stakeholder-driven method for selecting implementation strategies: a case example of pediatric hypertension clinical practice guideline implementationAshley A Knapp, Allison J Carroll, Nivedita Mohanty, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Pediatric Nephrology (Berlin, Germany)|April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenChantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Journal of Clinical Medicine|July 14, 2023
Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium StudyAli Mirza Onder, Md Abu Yusuf Ansari, Fang Deng, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Nephrology|June 30, 2021
Conversion to permanent vascular access is associated with improved markers of hemodialysis efficacy in children: Pediatric nephrology research consortium studyAli Mirza Onder, Joseph T Flynn, Md Abu Yusuf Ansari, et al.
Pediatric Nephrology (Berlin, Germany)|November 8, 2019
Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium studyAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pediatric Nephrology (Berlin, Germany)|September 29, 2018
Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patientsAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pediatric Nephrology (Berlin, Germany)|January 27, 2019
Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patientsAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Lupus|January 10, 2018
Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controlsI G Poornima, K Shields, L H Kuller, et al.
Implementation Science Communications|March 8, 2022
A stakeholder-driven method for selecting implementation strategies: a case example of pediatric hypertension clinical practice guideline implementationAshley A Knapp, Allison J Carroll, Nivedita Mohanty, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Pediatric Nephrology (Berlin, Germany)|April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenChantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Journal of Clinical Medicine|July 14, 2023
Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium StudyAli Mirza Onder, Md Abu Yusuf Ansari, Fang Deng, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Nephrology|June 30, 2021
Conversion to permanent vascular access is associated with improved markers of hemodialysis efficacy in children: Pediatric nephrology research consortium studyAli Mirza Onder, Joseph T Flynn, Md Abu Yusuf Ansari, et al.
Pediatric Nephrology (Berlin, Germany)|November 8, 2019
Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium studyAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pediatric Nephrology (Berlin, Germany)|September 29, 2018
Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patientsAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pediatric Nephrology (Berlin, Germany)|January 27, 2019
Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patientsAli Mirza Onder, Joseph T Flynn, Anthony A Billings, et al.
Pageof 19